Corbus Pharmaceuticals Holdings (CRBP) EPS (Basic) (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly EPS (Basic) of -$1.98 for Q3 2025, down 31.66% year-over-year from -$2.9 in Q3 2024, and down 26.8% quarter-over-quarter from -$1.56 in Q2 2025.
Corbus Pharmaceuticals Holdings (CRBP) EPS (Basic) (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' EPS (Basic) history runs 13 years deep, the most recent figure standing at -$1.98 for Q3 2025.
- In Q3 2025, EPS (Basic) fell 31.66% year-over-year to -$1.98; the TTM figure through Dec 2025 stood at -$5.39 (up 8.38% YoY), while the FY2024 annual figure was -$4.72, up 85.41% from the prior year.
- EPS (Basic) for Q3 2025 stood at -$1.98, down from -$1.56 in the prior quarter.
- The five-year high for EPS (Basic) was -$1.15 in Q4 2024, with the low at -$13.91 in Q2 2021.
- The 5-year median for EPS (Basic) is -$2.55 (2021), against an average of -$4.72.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) surged 83.48% in 2022, then sank 97.83% in 2023.
- Corbus Pharmaceuticals Holdings' EPS (Basic) stood at -$2.55 in 2021, then decreased by 17.63% to -$2.99 in 2022, then gained by 17.22% to -$2.48 in 2023, then surged by 53.67% to -$1.15 in 2024, then tumbled by 72.79% to -$1.98 in 2025.
- Business Quant data shows CRBP's EPS (Basic) at -$1.98 in Q3 2025, -$1.56 in Q2 2025, and -$1.87 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Corbus Pharmaceuticals Holdings | 121.72 Mn | -41.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.98 |
| Jun 30, 2025 | -1.56 |
| Mar 31, 2025 | -1.87 |
| Dec 31, 2024 | -1.15 |
| Sep 30, 2024 | -1.51 |
| Jun 30, 2024 | -2.10 |
| Mar 31, 2024 | -1.26 |
| Dec 31, 2023 | -2.48 |
| Sep 30, 2023 | -6.85 |
| Jun 30, 2023 | -6.77 |
| Mar 31, 2023 | -4.36 |
| Dec 31, 2022 | -2.99 |
| Sep 30, 2022 | -4.59 |
| Jun 30, 2022 | -5.55 |
| Mar 31, 2022 | -2.20 |
| Dec 31, 2021 | -2.55 |
| Sep 30, 2021 | -12.62 |
| Jun 30, 2021 | -13.91 |
| Mar 31, 2021 | -13.35 |
| Dec 31, 2020 | -8.25 |